Caution Lingers for STAAR Surgical Amid Middle East Geopolitical Tensions
STAAR Surgical expects preliminary Q2 2026 net sales to top $90 million, driven by strong Americas growth and an inventory rebound in China.
Why It Matters
STAAR Surgical expects strong sales growth next quarter, mainly from the Americas and restocking in China. However, some people are worried about problems in the Middle East that could affect the company's future business.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.